Health-care activists, a lawyer said, India's Supreme Court struck down the patent medicine manufacturers novartis the rights of the new version of a life-saving cancer drugs.
Landmark ruling is a victory on Monday, India $2.6 billion generic drugs industry all over the world millions of cheap drugs.
Ruling precedent, in order to prevent the international pharmaceutical companies in India existing drugs patented new updated version.
Attorney grover, anand, said the ruling could help the poor get affordable, generic versions of life-saving medicines.
As a new leukemia drug patent, since 2006, in India, novartis has made a legal battle.
The Indian Patent Office rejected the company's patent application, because it is not a new drug.
 



Other News:
U.S. Wargames North Korean Regime Collapse, Invasion to Secure Nukes
Drug maker loses India patent battle
Bearing type for radiator
France revises up deficits for past 2 years
Caribbean nations search for oil amid spill fears
Oregon wave energy project may be delayed
NKorea orders rocket prep after US B-2 drill
Sanctions noose makes it harder for Japan's Koreans to help their own